Quantitative assessment of time dependent drug-use trends by the analysis of drugs and related metabolites in raw sewage

Drug and Alcohol Dependence

Volumn 119, Issue 3, 2011, Pages 179-186

  Reid, Malcolm J ^a   Langford, Katherine H ^a   Mørland, Jørg ^b   Thomas, Kevin V ^a  

^a NORWEGIAN INSTITUTE FOR WATER RESEARCH   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Cocaine; Drug epidemiology; Methamphetamine; Sewage analysis

Indexed keywords

CETIRIZINE; COCAINE; METHAMPHETAMINE; METOPROLOL;

ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG USE; FLOW KINETICS; HUMAN; METABOLITE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; QUANTITATIVE ANALYSIS; SEWAGE; SEWAGE TREATMENT PLANT; URINALYSIS;

HALF-LIFE; HUMANS; PRESCRIPTION DRUGS; SEWAGE; SOLID PHASE EXTRACTION; STREET DRUGS; SUBSTANCE ABUSE DETECTION; TIME FACTORS; WATER POLLUTANTS, CHEMICAL;

EID: 82555189788     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.06.007     Document Type: Article

References (62)

1. Ambre J. The urinary excretion of cocaine and metabolites in humans: a kinetic analysis of published data. J. Anal. Toxicol. 1985, 9:241-245.
2. Ambre J. Urinary excretion of ecgonine methyl ester, a major metabolite of cocaine in humans. J. Anal. Toxicol. 1984, 8:23-25.
3. Ambre J., Ruo T., Nelson J. Urinary excretion of cocaine, benzoylecgonine, and ecgonine methyl ester in humans. J. Anal. Toxicol. 1988, 12:301-306.
4. Banta-Green C.J., Field J.A., Chiaia A.C., Sudakin D.L., Power L., de Montigny L. The spatial epidemiology of cocaine, methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) use: a demonstration using a population measure of community drug load derived from municipal wastewater. Addiction 2009, 104:1874-1880.
5. Basurto F.Z., Montes J.M.G., Cubos P.F., Santed F.S., Rios F.L., Moreno A.M. Validity of the self-report on drug use by university students: correspondence between self-reported use and use detected in urine. Psicothema 2009, 21:213-219.
6. Bones J., Thomas K.V., Paull B. Using environmental analytical data to estimate levels of community consumption of illicit drugs and abused pharmaceuticals. J. Environ. Monit. 2007, 9:701.
7. Buchan B.J., Dennis M.L., Tims F.M., Diamond G.S. Cannabis use: consistency and validity of self-report, on-site urine testing and laboratory testing. Addiction 2002, 9:98-108.
8. Castiglioni S., Zuccato E., Crisci E., Chiabrando C., Fanelli R., Bagnati R. Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid chromatography-tandem mass spectrometry. Anal. Chem. 2006, 78:8421-8429.
9. Castiglioni S., Zuccato E., Fanelli R. Illicit Drugs in the Environment: Occurrence, Analysis, and Fate Using Mass Spectrometry 2011, John Wiley and Sons, Inc., New York.
10. Cerqueira P.M., Boralli V.B., Coelho E.B., Lopes N.P., Guimaraes L.F.L., Bonato P.S., Lanchote V.L. Enantioselective determination of metoprolol acidic metabolite in plasma and urine using liquid chromatography chiral columns: applications to pharmacokinetics. J. Chromatogr. B. 2003, 783:433-441.
11. Cho A.K., Melega W.P. Patterns of methamphetamine abuse and their consequences. J. Addict. Dis. 2002, 21:21-34.
12. Cone E.J. Pharmacokinetics and pharmacodynamics of cocaine. J. Anal. Toxicol. 1995, 19:459-478.
13. Cone E.J. Recent discoveries in pharmacokinetics of drugs of abuse. Toxicol. Lett. 1998, 102:97-101.
14. Cone E.J., Sampson-Cone A., Darwin W., Huestis M., Oyler J. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results. J. Anal. Toxicol. 2003, 27:386-401.
15. Cone E.J., Tsadik A., Oyler J., Darwin W.D. Cocaine metabolism and urinary excretion after different routes of administration. Ther. Drug Monit. 1998, 20:556-560.
16. Cook C.E., Jeffcoat A.R., Sadler B.M., Hill J.M., Voyksner R.D., Pugh D.E., White W.R., Perez-Reyes M. Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans. Drug Metab. Dispos. 1992, 20:856-862.
17. European Monitoring Centre for Drugs and Drug Addiction, 2009. Analysis of the Drug Situation in Europe: Statistical Bulletin 2009. Available from: http://www.emcdda.europa.eu/stats09.
18. European Monitoring Centre for Drugs and Drug Addiction, 2010. The state of the drugs problem in Europe. EMCDDA Annual Report. Available from: http://www.emcdda.europa.eu/publications/annual-report/2010.
19. Fergusson D.M.L., Horwood J., Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 2002, 97:1123-1135. 10.1046/j.1360-0443.2002.00103.x.
20. Gheorghe A., Nuijs A., Pecceu B., Bervoets L., Jorens P.G., Blust R., Neels H., Covaci A. Analysis of cocaine and its principal metabolites in waste and surface water using solid-phase extraction and liquid chromatography-ion trap tandem mass spectrometry. Anal. Bioanal. Chem. 2008, 391:1309-1319.
21. Gossop M., Marsden J., Stewart D., Rolfe A. Reductions in acquisitive crime and drug use after treatment of addiction problems: 1-year follow-up outcomes. Drug Alcohol Depend. 2000, 58:165-172. 10.1016/S0376-8716(99)00077-0.
22. Grung M., Källqvist T., Sakshaug S., Skurtveit S., Thomas K.V. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline. Ecotoxicol. Environ. Saf. 2008, 71:328-340.
23. Harris D.S., Everhart E.T., Mendelson J., Jones R.T. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend. 2003, 72:169-182.
24. Harris K.M, Griffin B.A., McCaffrey D.F., Morral A.R. Inconsistencies in self-reported drug use by adolescents in substance abuse treatment: implications for outcome and performance measurements. J. Subst. Abuse Treat. 2008, 34:347-355.
25. Harrison, L.D., Martin, S.S., Enev, T., Harrington, D., 2007. Comparing Drug Testing and Self-Report of Drug Use among Youths and Young Adults in the General Population. Substance Abuse and Mental Health Services Administration. DHHS Publication No. SMA 07-4249, Rockville, MD.
26. Huerta-Fontela M., Galceran M.T., Martin-Alonso J., Ventura F. Occurrence of psychoactive stimulatory drugs in wastewaters in north-eastern Spain. Sci. Total Environ. 2008, 397:31-40. 10.1016/j.scitotenv.2008.02.057.
27. Huerta-Fontela M., Galceran M.T., Ventura F. Stimulatory drugs of abuse in surface waters and their removal in a conventional drinking water treatment plant. Environ. Sci. Technol. 2008, 42:6809-6816. 10.1021/es800768h.
28. Jatlow P. Cocaine: analysis, pharmacokinetics, and metabolic disposition. Yale J. Biol. Med. 1988, 61:105.
29. Jiménez C., Ventura R., Segura J., de la Torre R. Protocols for stability and homogeneity studies of drugs for its application to doping control. Anal. Chim. Acta 2004, 515:323-331.
30. Karolak S., Nefau T., Bailly E., Solgadi A., Levi Y. Estimation of illicit drugs consumption by wastewater analysis in Paris area (France). Forensic Sci. Int. 2010, 200:153-160. 10.1016/j.forsciint.2010.04.007.
31. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. Illicit drugs and pharmaceuticals in the environment-forensic applications of environmental data. Part 1. Estimation of the usage of drugs in local communities. Environ. Pollut. 2009, 157:1773-1777.
32. Kroutil L.A., Vorburger M., Aldworth J., Colliver J.D. Estimated drug use based on direct questioning and open-ended questions: responses in the 2006 National Survey on Drug Use and Health. Int. J. Methods Psychiatr. Res. 2010, 19:74-87.
33. Küster A., Alder A.C., Escher B., Duis K., Fenner K., Garric J., Hutchinson T.H., Lapen D.R., Pery A., Rombke J., Snape J., Ternes T., Topp E., Wehrhan A., Knacker T. Environmental risk assessment of human pharmaceuticals in the European Union-a case study with the β-blocker atenolol. Integr. Environ. Assess. Manag. 2010, 6:514-523.
34. Laizure C.S., Mandrell T., Gades N.M., Parker R.B. Cocaethylene metabolism and interaction with cocaine and ethanol: role of carboxylesterases. Drug Metab. Dispos. 2003, 31:16-20.
35. Lund M.K.O., Lund K.E., Skretting A. Rusmiddelbruk blant unge voksne, 21-30 år□: resultater fra spørreskjemaundersøkelser 1998, 2002 og 2006 2007, SIRUS, Oslo.
36. Mari F., Politi L., Biggeri A., Accetta G., Trignano C., Di Padua M., Bertol E. Cocaine and heroin in waste water plants: a 1-year study in the city of Florence, Italy. Forensic Sci. Int. 2009, 189:88-92.
37. Murthy S.S., Umesha Shetty H., Nelson W.L., Jackson P.R., Lennard M.S. Enantioselective and diastereoselective aspects of the oxidative metabolism of metoprolol. Biochem. Pharmacol. 1990, 40:1637-1644.
38. Musshoff F., Driever A., Lachenmeier K., Lachenmeier D.W., Banger M., Madea B. Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests. Forensic Sci. Int. 2006, 156:118-123.
39. Ort C., Lawrence M.G., Rieckermann J., Joss A. Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? A critical review. Environ. Sci. Technol. 2010, 44:6024-6035. 10.1021/es100779n.
40. Oyler J.M., Cone E.J., Joseph R.E., Moolchan E.T., Huestis M.A. Duration of detectable methamphetamine and amphetamine excretion in urine after controlled oral administration of methamphetamine to humans. Clin. Chem. 2002, 48:1703-1714.
41. Postigo C., Lopezdealda M., Barcelo D. Analysis of drugs of abuse and their human metabolites in water by LC-MS2: a non-intrusive tool for drug abuse estimation at the community level. Trends Anal. Chem. 2008, 27:1053-1069.
42. Postigo C., López de Alda M., Barceló D. Evaluation of drugs of abuse use and trends in a prison through wastewater analysis. Environ. Int. 2011, 37:49-55. 10.1016/j.envint.2010.06.012.
43. Quarterman C.P., Kendall M.J., Jack D.B. The effect of age on the pharmacokinetics of metoprolol and its metabolites. Br. J. Clin. Pharmacol. 1981, 11:287-294.
44. Radjenovic J., Perez S., Petrovic M., Barcelo D. Identification and structural characterization of biodegradation products of atenolol and glibenclamide by liquid chromatography coupled to hybrid quadrupole time-of-flight and quadrupole ion trap mass spectrometry. J. Chromatogr. A. 2008, 1210:142-153.
45. Rawson R., Huber A., Brethen P., Obert J., Gulati V., Shoptaw S., Ling W. Methamphetamine and cocaine users: differences in characteristics and treatment retention. J. Psychoactive Drugs 2000, 32:233-238.
46. Reid M.J., Langford K.H., Mørland J., Thomas K.V. Analysis and interpretation of specific ethanol metabolites, ethyl sulfate and ethyl glucuronide, in sewage effluent for the quantitative measurement of regional alcohol consumption. Alcohol. Clin. Exp. Res. 2011, 35(9):1-7. 10.1111/j.1530-0277.2011.01505.x.
47. Rowney N.C., Johnson A.C., Williams R.J. Cytotoxic drugs in drinking water: a prediction and risk assessment exercise for the Thames catchment in the United Kingdom. Environ. Toxicol. Chem. 2009, 28:2733-2743.
48. Sakshaug S., Strøm H., Lie Berg C., Litleskare I., Salvesen Blix H., Rønning M. Drug Consumption in Norway 2005-2009 2010, Norwegian Institute of Public Health, Oslo.
49. Shima N., Kamata H.T., Katagi M., Tsuchihashi H. Urinary excretion of the main metabolites of methamphetamine, including p-hydroxymethamphetamine-sulfate and p-hydroxymethamphetamine-glucuronide, in humans and rats. Xenobiotica 2006, 36:259-267.
50. Shimosato K. Urinary excretion of p-hydroxylated methamphetamine metabolites in man. II. Effect of alcohol intake on methamphetamine metabolism. Pharmacol. Biochem. Behav. 1988, 29:733-740.
51. Shimosato K., Oda H., Ohmae M., Tomita M., Doi Y. Biphasic effects of alcohol drinking on methamphetamine metabolism in man. Alcohol Alcohol. 1988, 23:351-357.
52. Simon S., Richardson K., Dacey J., Glynn S., Domier C., Rawson R., Ling W. A comparison of patterns of methamphetamine and cocaine use. J. Addict. Dis. 2002, 21:35-44.
53. Stuer-Lauridsen F., Birkved M., Hansen L., Holten Lutzhoft H.C., Halling-Sorensen B. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 2000, 40:783-789.
54. Substance Abuse and Mental Health Services Administration, 2009. Results from the 2008 National Survey on Drug Use and Health: National Findings. Office of Applied Studies NSDUH Series H-36. Office of Applied Studies, NSDUH Series H-36, Rockville, MD.
55. ter Laak T.L., van der Aa M., Houtman C.J., Stoks P.G., van Wezel A.P. Relating environmental concentrations of pharmaceuticals to consumption: a mass balance approach for the river Rhine. Environ. Int. 2010, 36:403-409.
56. New Research on Methamphetamine Abuse 2007, Nova Publishers, New York. G.H. Toolaney (Ed.).
57. van Nuijs A., Castiglioni S., Tarcomnicu I., Postigo C., Lopez de Alda M., Neels H., Zuccato E., Barcelo D., Covaci A. Illicit drug consumption estimations derived from wastewater analysis: a critical review. Sci. Total Environ. 2010, [epub ahead of print].
58. van Nuijs A., Pecceu B., Theunis L., Dubois N., Charlier C., Jorens P.G., Bercoets L., Blust R., Neels H., Covaci A. Spatial and temporal variations in the occurrence of cocaine and benzoylecgonine in waste-and surface water from Belgium and removal during wastewater treatment. Water Res. 2009, 43:1341-1349.
59. van Nuijs A., Pecceu B., Theunis L., Dubois N., Charlier C., Jorens P.G., Bervoets L., Blust R., Meulemans H., Neels H., Covaci A. Can cocaine use be evaluated through analysis of wastewater? A nation-wide approach conducted in Belgium. Addiction 2009, 104:734-741.
60. Watson W.T.A., Simons K.J., Chen X.Y., Simons F.E.R. Cetirizine: a pharmacokinetic and pharmacodynamic evaluation in children with seasonal allergic rhinitis. J. Allergy Clin. Immunol. 1989, 84:457-464.
61. Wood S.G., Chasseaud L.F., Yeh J., Chung M. The metabolism and pharmacokinetics of 14C-cetirizine in humans. Ann. Allergy 1987, 59:31-34.
62. Zuccato E., Chiabrando C., Castiglioni S., Bagnati R., Fanelli R. Estimating community drug abuse by wastewater analysis. Environ. Health Perspect. 2008, 116:1027-1032.